BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 9020859)

  • 1. Comparative studies of rat recombinant purple acid phosphatase and bone tartrate-resistant acid phosphatase.
    Ek-Rylander B; Barkhem T; Ljusberg J; Ohman L; Andersson KK; Andersson G
    Biochem J; 1997 Jan; 321 ( Pt 2)(Pt 2):305-11. PubMed ID: 9020859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porcine purple acid phosphatase: heterologous expression, characterization, and proteolytic analysis.
    Naseri JI; Truong NT; Hörentrup J; Kuballa P; Vogel A; Rompel A; Spener F; Krebs B
    Arch Biochem Biophys; 2004 Dec; 432(1):25-36. PubMed ID: 15519293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tartrate-resistant purple acid phosphatase is synthesized as a latent proenzyme and activated by cysteine proteinases.
    Ljusberg J; Ek-Rylander B; Andersson G
    Biochem J; 1999 Oct; 343 Pt 1(Pt 1):63-9. PubMed ID: 10493912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant purple acid phosphatase isoform 3 from sweet potato is an enzyme with a diiron metal center.
    Waratrujiwong T; Krebs B; Spener F; Visoottiviseth P
    FEBS J; 2006 Apr; 273(8):1649-59. PubMed ID: 16623702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-glycosylation influences the latency and catalytic properties of mammalian purple acid phosphatase.
    Wang Y; Norgård M; Andersson G
    Arch Biochem Biophys; 2005 Mar; 435(1):147-56. PubMed ID: 15680916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tartrate-resistant bone acid phosphatase: large-scale production and purification of the recombinant enzyme, characterization, and crystallization.
    Kaija H; Jia J; Lindqvist Y; Andersson G; Vihko P
    J Bone Miner Res; 1999 Mar; 14(3):424-30. PubMed ID: 10027907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and expression of tartrate-resistant acid phosphatase (TRAP) in hematopoietic cells.
    Drexler HG; Gignac SM
    Leukemia; 1994 Mar; 8(3):359-68. PubMed ID: 8127141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purple acid phosphatase of the human macrophage and osteoclast. Characterization, molecular properties, and crystallization of the recombinant di-iron-oxo protein secreted by baculovirus-infected insect cells.
    Hayman AR; Cox TM
    J Biol Chem; 1994 Jan; 269(2):1294-300. PubMed ID: 8288593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of the interaction between active site residues and the loop region in mammalian purple acid phosphatases.
    Funhoff EG; Ljusberg J; Wang Y; Andersson G; Averill BA
    Biochemistry; 2001 Sep; 40(38):11614-22. PubMed ID: 11560512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a tartrate-resistant acid phosphatase (ATPase) from rat bone: hydrodynamic properties and N-terminal amino acid sequence.
    Ek-Rylander B; Bergman T; Andersson G
    J Bone Miner Res; 1991 Apr; 6(4):365-73. PubMed ID: 1830446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and distribution of tartrate-resistant purple acid phosphatase in the rat nervous system.
    Lång P; Schultzberg M; Andersson G
    J Histochem Cytochem; 2001 Mar; 49(3):379-96. PubMed ID: 11181741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tartrate-resistant acid phosphatase from human bone: purification and development of an immunoassay.
    Halleen J; Hentunen TA; Hellman J; Väänänen HK
    J Bone Miner Res; 1996 Oct; 11(10):1444-52. PubMed ID: 8889844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatase and oxygen radical-generating activities of mammalian purple acid phosphatase are functionally independent.
    Kaija H; Alatalo SL; Halleen JM; Lindqvist Y; Schneider G; Väänänen HK; Vihko P
    Biochem Biophys Res Commun; 2002 Mar; 292(1):128-32. PubMed ID: 11890682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of purple acid phosphatase from developing rat bone.
    Anderson TR; Toverud SU
    Arch Biochem Biophys; 1986 May; 247(1):131-9. PubMed ID: 3085593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of human bone tartrate-resistant acid phosphatase.
    Allen SH; Nuttleman PR; Ketcham CM; Roberts RM
    J Bone Miner Res; 1989 Feb; 4(1):47-55. PubMed ID: 2718778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of a mammalian purple acid phosphatase.
    Uppenberg J; Lindqvist F; Svensson C; Ek-Rylander B; Andersson G
    J Mol Biol; 1999 Jul; 290(1):201-11. PubMed ID: 10388567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human and mouse purple acid phosphatases: expression and characterization.
    Marshall K; Nash K; Haussman G; Cassady I; Hume D; de Jersey J; Hamilton S
    Arch Biochem Biophys; 1997 Sep; 345(2):230-6. PubMed ID: 9308894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the protein tyrosine phosphatase activity of tartrate-resistant acid phosphatase.
    Halleen JM; Kaija H; Stepan JJ; Vihko P; Väänänen HK
    Arch Biochem Biophys; 1998 Apr; 352(1):97-102. PubMed ID: 9521821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizations of recombinant human tartrate-resistant acid phosphatase from osteosarcoma: comparison study between recombinant and placental proteins.
    Miyazaki S; Igarashi M; Nagata A; Komoda T
    Methods Find Exp Clin Pharmacol; 2001 Oct; 23(8):433-9. PubMed ID: 11838317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning, sequence, and developmental expression of a type 5, tartrate-resistant, acid phosphatase of rat bone.
    Ek-Rylander B; Bill P; Norgård M; Nilsson S; Andersson G
    J Biol Chem; 1991 Dec; 266(36):24684-9. PubMed ID: 1722212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.